AFOS 2023 Taiwan

The 8th Asian Federation of Osteoporosis Societies Congress &

the 26th Taiwanese Osteoporosis Association Scientific Conference

Oct 13-15, 2023
Linkou Chang Gung Memorial Hospital, International Conference Hall, Taoyuan City, Taiwan
Day 1

Day 2
Saturday, 14 Oct, 2023

Day 3
Time Hall 1

Plenary lecture 3

Jawl-Shan Hwang黃兆山、Rong-Sen Yang楊榮森、Vilai Kuptniratsaikul
  1. Elucidating very high risk: build bone first to prevent imminent fracture
    Serge Ferrari(video-recorded)

Plenary lecture 4

Jawl-Shan Hwang黃兆山、Rong-Sen Yang楊榮森、Vilai Kuptniratsaikul
  1. Current status and achievements of osteoporosis care in Taiwan
    Jawl-Shan Hwang黃兆山

Plenary lecture 5

Jawl-Shan Hwang黃兆山、Rong-Sen Yang楊榮森、Vilai Kuptniratsaikul
  1. Effect of osteoporotic fracture and anti-osteoporosis treatment on mortality
    Chih-Hsing Wu吳至行

Break
Hall 1 Hall 2

Symposium 3: Individualize the treatment of osteoporosis

Shue-Fen Luo羅淑芬、Yin-Fan Chang張尹凡、Satoshi Mori
  1. Optimize the treatment outcomes for very high risk osteoporosis patients
    Fernando Marin
  2. Denosumab sequential therapy: Known and Unknown
    Shau-Huai Fu傅紹懷
  3. Use of Raloxifene in Treatment of Osteoporosis
    Kyu Ri Hwang

Symposium 4: Management for osteoporotic fractures: Not just operation

Chung-Hwan Chen陳崇桓、Hongsen Chiang江鴻生、Joon-Kiong Lee
  1. Fix and Treat Experience from Europe. How to save lives in Patients with Fragility fractures: The role of orthopedic surgeon
    Francisco Javier Nistal Rodríguez
  2. Osteoporotic hip Fracture surgical treatment and postoperative care
    Kwang-Kyoun Kim
  3. Fragile Fracture, Once is Enough
    Huipeng Shi(video-recorded)

TOA General Meeting 中華民國骨質疏鬆症學會會員大會

TOA General Meetng
Lunch Symposium

(The speech will be live broadcast on Hall 2 & 3)

Lunch Symposium (Sponsored by ZP THERAPEUTICS)

Chi-Chien Niu牛自健
  1. Update of the Management of Severe Osteoporosis with Teriparatide
    Fernando Marin

Symposium 5: Glucocorticoid induced osteoporosis and secondary osteoporosis

Tien-Tsai Cheng鄭添財、Swan Sim Yeap、Julie Li-Yu
  1. What's new in glucocorticoid-induced osteoporosis?
    Swan Sim Yeap
  2. Secondary Causes of Bone Loss
    Julie Li-Yu
  3. RA-related Osteoporosis/fracture
    Chung-Yuan Hsu許鐘元
  4. Application of Trabecular Bone Score for Fracture Risk Assessment in Rheumatic Patients
    Jia-Feng Chen陳嘉夆

Symposium 6: Long term care of fragile patients

Wing Chan陳榮邦、Ching-Lin Tsai蔡清霖、Chien-An Shih施建安
  1. Set your target: treatment goal with short and long term denosumab to prevent fracture
    Serge Ferrari(video-recorded)
  2. Sarcopenia and frailty
    Vilai Kuptniratsaikul
  3. Japanese action preventing secondary fragility fracture
    Satoshi Mori

Industry Symposium (Sponsored by AIM): From Pixels to Prevention: AI-Powered Digital Radiogrammetry Democratizes Osteoporosis Diagnosis

Qingzong Tseng曾慶宗

Break

Symposium 7: Treatment and prevention of osteoporosis in Taiwan for the past 25 years

Chih-Hsing Wu吳至行、Ding-Cheng Chan詹鼎正、Ang Seng Bin
  1. Cost and effectiveness analyses of the anti-osteoporosis medication in patients with hip fracture in Taiwan: A population-based national claims database analysis
    Chen-Yu Wang王貞予
  2. Long dosing intervals of antiosteoporosis medications decrease societal fracture risk: a 11-year nationwide population-based cohort study
    Shau-Huai Fu傅紹懷
  3. Asia-Pacific Consensus on Osteoporosis Prevention in Postmenopausal Women with Low Bone Mass or Osteoporosis without Fractures
    Chun-Feng Huang黃駿豐

Symposium 8: Anti-osteoporosis medication-related Osteonecrosis of Jaws

Jang-Jaer Lee李正喆、Ken-Chung Chen陳畊仲、Sung-Yen Lin林松彥
  1. Reliability of nonspecific symptoms or clinical findings of MRONJ at early stages: The Japanese Osteoporosis Intervention Trial-05 (JOINT-05)
    Akira Taguchi
  2. Management approaches and their outcomes of MRONJ
    Ken-Chung Chen陳畊仲
  3. Prognosis of MRONJ in patients Using Antiresorptive Agents
    Ling-Ying Wei魏鈴穎

Time Hall 3 (Mandarin)

TOA Section 1

Chun-Feng Huang黃駿豐、Ta-Wei Tai戴大為、Jen-Jia Yang楊鎮嘉
  1. The Consensus and Guidelines for the prevention and treatment of adult osteoporosis in Taiwan in 2023
    台灣成人骨質疏鬆症防治之共識及指引
    Chun-Feng Huang黃駿豐
  2. From Ground Zero to Glory: Charting the Path to a Gold Medal in Fracture Liaison Services at the Osteoporosis Center of Ditmanson Medical Foundation Chia-Yi Christian Hospital
    從0到1: 嘉基骨鬆中心的FLS金牌之路
    Cheng-Yi Wu吳政誼
  3. Master your Musculoskeletal Health, Keeping Sarcopenia and Osteoporosis Away
    掌握關鍵增肌顧骨，遠離健康隱形殺手
    Der-Sheng Han韓德生

Break

TOA Section 2

Hsuan-Jui Chang張軒睿、Huei-Kai Huang黃暉凱
  1. Considerations in Medication Treatment for Osteoporosis
    骨鬆用藥衛教重點
    Szu-Han Lin林思涵
  2. Transforming Health Education with a Touch of Magic: An Innovative Approach
    幻變的健康教育：魔術的創新應用與實踐
    Kuan Ting Lee李貫廷

TOA General Meeting 中華民國骨質疏鬆症學會會員大會

Lunch

TOA Section 3

Tien-Ching Lee李天慶、Szu-Han Lin林思涵
  1. Osteoporosis Health Education and Presentation Workshop(I): Through Heart-touching Narratives
    骨鬆衛教與簡報工作坊(I):
    用故事深入人心
    Huai-Jing Yu余懷瑾
  2. Osteoporosis Health Education and Presentation Workshop (II): Persuade Your Audience through Effective Presentation
    骨鬆衞教與簡報工作坊(II):
    用簡報說服受眾
    Wei-Min Chu朱為民

Break

Taiwan Sng Society & Taiwanese Osteoporosis Association Joint Academic Symposium台灣痠痛研究學會&中華民國骨質疏鬆症學會聯合學術研討會

Der-Sheng Han韓德生、Chih-Cheng Chen陳志成
  1. Theory of “sng pain”
    Chih-Cheng Chen陳志成
  2. New Insights into the Molecular Mechanisms Contributing to Osteoporosis Development
    Feng-Sheng Wang王逢興
  3. Sng and osteoporotic fractures
    Jiann-Her Lin林建和

Time Hall 4

AFOS Oral Competition

Gau-Tyan Lin林高田、Chun-Han Hou侯君翰、Yi-Jan Gau高義然、Shau-Huai Fu傅紹懷、Ching-Lung Cheung
  1. A01 Sequential Therapy with Denosumab and Zoledronate for Osteoporosis Management A Randomized Controlled Trial
    Hung-Kuan Yen
  1. A02 Treatment Persistence and Medication Switch Associated with Subsequent Fractures after Osteoporotic Fractures
    Sung-Yen Lin
  1. A03 The First-Year Results of Denosumab Sequential Therapy (DST) Trial – An Open-label Multi-institutional Randomised Controlled Trial to Investigate the Better Strategy for Sequential Therapy with Zoledronate after Denosumab Cessation
    Chia-Che Lee
  1. A04 Nitrogen-containing bisphosphonate was associated with a lower risk of dementia in patients with fragility fractures: a population-based cohort study in Hong Kong
    Chor-Wing Sing
  1. A05 Lower risk of subsequent fracture among hip fracture patients: Long dosing interval of antiosteoporosis medication matters
    Chen-Yu Wang
  1. A06 Drug Adherence And Treatment Duration Of Denosumab Have An Influence On Patient’ All-cause Mortality After Hip Fracture Surgery
    Yi-Lun Tsai
  1. A07 Utilize Polygenic Risk Score to Predict Fragility Fracture and Improve the Performance of FRAX in Patients with Osteoporosis
    Jian-Jiun Chen
  1. A08 Fracture risk assessment from 2D DXA scan by supervised machine learning modeling
    Heesun Choi
  1. A09 Application of deep learning algorithm to detect and visualize vertebral fractures on plain radiographs
    Hsuan-Yu Chen
  1. A10 Establish and Validate the Reliability of Predictive Models in Bone Mineral Density by Deep Learning as Examination Tool for Women
    Wei-Chieh Hung
  1. A11 Revolutionizing Osteoporosis Detection: AI-Enhanced Chest X-Ray Unveils Bone Mineral Density
    Wen-Hui Fang
  1. A12 Risk factors for mortality, fractures and falls among patients participating in a Fracture Liaison Service program: a machine learning approach
    Christina Soong

Break
  1. A13 Measurement of the areal and volumetric bone mineral density of the proximal femur from hip X-rays
    Keisuke Uemura
  1. A14 Screening of fracture risk and osteoporosis among older long-term care residents: A before–after intervention study
    Cheng Yo Lai
  1. A15 Optimal Osteoporosis Treatment Candidates in Long-Term Care and Nursing Home Residents: Balancing Mortality Considerations
    Ting-En Tseng
  1. A16 Epidemiology of hip fractures in Thailand
    Natthinee Charatcharoenwitthaya
  1. A17 A Nomogram for Prediction of 1-Year Postoperative Mortality Risk in geriatric patients with a hip fracture
    Cheng-Yi Wu
  1. A18 Comprehensive Geriatric Assessment for identifying mortality risk in older patients after hip fracture surgery
    Nai-Chen Shih
  1. A19 The Effects of Omega-3 Polyunsaturated Fatty Acids on Muscle Protein Synthesis: A Systematic Review and Meta-analysis
    Atiporn Therdyothin
  1. A20 The intercorrelation of vitamin D deficiency and SPP1 (Osteopontin) genetic polymorphisms with bone mineral density in middle-aged women. A cross-sectional study
    Ying-Hao Su
  1. A21 Effects of palm tocotrienol on cartilage and subchondral bone in ovariectomized rats with osteoarthritis
    Kok-Yong Chin